US EditionCompanies Criticise Non-Incorporation of Wegovy in Sus - 23/08/2025 - Balance and Health
Summary by Folha De S.Paulo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Tr's association is m words expressed against the decision of the Contec or of the Contector (Committee or National of Incorporation is of Technologies) of n or incorporating liraglutida (Saxenda) and semi-megalutida (Wegovy) in SUS (SUS Nico de Sa's System). Read more (08/23/2025)
·São Paulo, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
